Navigation Links
Sequenom Announces Date of Second Quarter 2010 Financial Results and Conference Call
Date:7/29/2010

SAN DIEGO, July 29 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM), will report second quarter 2010 financial results after market close on Thursday August 5, 2010.  The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.

Conference Call Information:

Domestic callers: 1- 866-783-2144

International callers: +1- 857-350-1603

Passcode: 73790882

Webcast information: Visit http://ir.sequenom.com.

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).

A webcast replay will be available on the Sequenom Web site for 30 days.  A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-888-286-8010 for domestic callers, or +1-617-801-6888 for international callers, and entering reservation code 33127322.

About Sequenom

Sequenom, Inc. (Nasdaq: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at http://www.sequenom.com to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.

SEQUENOM® is a trademark of Sequenom, Inc. All other trademarks and service marks are the property of their respective owners.


'/>"/>
SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sequenom to Present at the Jefferies 2010 Global Life Sciences Conference
2. Sequenom Announces Final Approval of Settlement in Class Action Securities Lawsuit
3. Sequenom Reports 2009 Fourth Quarter and Full Year Financial Results
4. Sequenom Announces Launch of SensiGene Fetal(XY) (Fetal Sex Determination) Test
5. Sequenom Announces Addition to Clinical Advisory Board
6. Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit
7. Sequenom Announces Paul Maier to Become Interim Chief Financial Officer
8. University of Michigan Study Shows SEQUENOMs MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
9. Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
10. IRIDEX Announces Second Quarter 2010 Conference Call and Release Date
11. Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... LAKE, N.J. , Jan. 18, 2017 /PRNewswire/ ... Co., Ltd., announced today that it is participating ... access to non-communicable diseases (NCDs) prevention, treatment and ... Access Accelerated is the first multi-stakeholder, international ... 22 major pharmaceutical companies, including Eisai, in collaboration ...
(Date:1/18/2017)... 2017 ML Capital Group ... publish an online presentation tomorrow, January 19 th ... for 2017. Management reports that the forecast is ... performance from its existing operations, and the anticipated ... the Cannabis sector through a partnership with ...
(Date:1/18/2017)... 2017  Astellas Pharma Inc. (President and CEO: ... its participation in Access Accelerated, a global, multi-stakeholder ... prevention, diagnostics and treatment in low-income and lower-middle ... companies and in collaboration with the World Bank ... (UICC), Astellas will work towards the United Nations ...
Breaking Medicine Technology:
(Date:1/17/2017)... California (PRWEB) , ... January 17, 2017 , ... ... have a point of difference. Eden Activewear is a stand-out company for several ... are exclusively online and only manufacture on demand, this is called 'Agile' manufacturing ...
(Date:1/17/2017)... ... January 17, 2017 , ... Healthful Balance announces ... company, owned and operated by Ed Stroup, was created to offer the highest ... highest level of customer service. Healthful Balance products can be purchased online through ...
(Date:1/17/2017)... Grove Village, IL (PRWEB) , ... January 17, ... ... for musicians and music enthusiasts at the National Association of Music Merchants (NAMM) ... January 19 – 22, 2017. , Etymotic’s ER•4® has long been the gold ...
(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, Houston’s ... honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, MD ... elite group of providers. , Produced by Zeltiq, CoolSculpting is approved by the ...
(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons from ... primary eye care practitioners on the latest breakthroughs in the prevention, diagnosis and ... Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer ...
Breaking Medicine News(10 mins):